Anna C. Calkin, et.al., Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice., Circulation research, 2014, 115

http://rdf.ncbi.nlm.nih.gov/pubmed/24935961

Anna C. Calkin, et.al., Transgenic expression of dominant-active IDOL in liver causes diet-induced hypercholesterolemia and atherosclerosis in mice., Circulation research, 2014, 115

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(Alb-MYLIP*)1Pton
  http://metadb.riken.jp/db/mgi_rdf/MGI:5706928

class

http://purl.org/net/cito/citesAsAuthority

• Tg(Alb-MYLIP*)1Pton
  http://metadb.riken.jp/db/mgi_rdf/MGI:5706928

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal body fat mass_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0012320IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• increased circulating cholesterol level_Ldlr<tm1Her>/Ldlr<tm1Her>
  http://metadb.riken.jp/0005178I129S7SvEvBrdLdlrtm1HerLdlrtm1HerLdlrtm1Her
• atherosclerotic lesions_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0005338IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• increased susceptibility to atherosclerosis_Ldlr<tm1Her>/Ldlr<tm1Her>
  http://metadb.riken.jp/0005339I129S7SvEvBrdLdlrtm1HerLdlrtm1HerLdlrtm1Her
• increased circulating cholesterol level_Tg(APOE_i3*,APOC1)2Lmh/?
  http://metadb.riken.jp/0005178IC57BL6JCBATgAPOEi3APOC12LmhTgAPOEi3APOC12Lmh
• increased susceptibility to atherosclerosis_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0005339IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• increased circulating LDL cholesterol level_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0000182IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• increased circulating triglyceride level_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0001552IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• increased circulating LDL cholesterol level_Tg(APOE_i3*,APOC1)2Lmh/?
  http://metadb.riken.jp/0000182IC57BL6JCBATgAPOEi3APOC12LmhTgAPOEi3APOC12Lmh
• increased circulating triglyceride level_Tg(APOE_i3*,APOC1)2Lmh/?
  http://metadb.riken.jp/0001552IC57BL6JCBATgAPOEi3APOC12LmhTgAPOEi3APOC12Lmh
• increased circulating VLDL cholesterol level_Tg(APOE_i3*,APOC1)2Lmh/?
  http://metadb.riken.jp/0005145IC57BL6JCBATgAPOEi3APOC12LmhTgAPOEi3APOC12Lmh
• decreased circulating triglyceride level_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0002644IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• atherosclerotic lesions_Tg(APOE_i3*,APOC1)2Lmh/?
  http://metadb.riken.jp/0005338IC57BL6JCBATgAPOEi3APOC12LmhTgAPOEi3APOC12Lmh
• increased susceptibility to atherosclerosis_Tg(APOE_i3*,APOC1)2Lmh/?
  http://metadb.riken.jp/0005339IC57BL6JCBATgAPOEi3APOC12LmhTgAPOEi3APOC12Lmh
• increased circulating cholesterol level_Tg(Alb-MYLIP*)1Pton/?
  http://metadb.riken.jp/0005178IC57BL6JTgAlbMYLIP1PtonTgAlbMYLIP1Pton
• atherosclerotic lesions_Ldlr<tm1Her>/Ldlr<tm1Her>
  http://metadb.riken.jp/0005338I129S7SvEvBrdLdlrtm1HerLdlrtm1HerLdlrtm1Her